Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adiuvo Investments's enterprise value is zł34.32 Mil.
Adiuvo Investments's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.50 Mil. Therefore, Adiuvo Investments's EV-to-EBITDA for today is 68.37.
The historical rank and industry rank for Adiuvo Investments's EV-to-EBITDA or its related term are showing as below:
WAR:ADV'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -35.25 Med: -4.71 Max: 78.46
Current: 68.37
During the past 13 years, the highest EV-to-EBITDA of Adiuvo Investments was 78.46. The lowest was -35.25. And the median was -4.71.
WAR:ADV's EV-to-EBITDA is ranked worse than 92.59% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.83
vs WAR:ADV: 68.37
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Adiuvo Investments's PE Ratio (TTM) for today is calculated as:
Adiuvo Investments's share price for today is zł0.522.
Adiuvo Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.320.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Adiuvo Investments's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Adiuvo Investments's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adiuvo Investments EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adiuvo Investments's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Adiuvo Investments's EV-to-EBITDA falls into.
Adiuvo Investments's current Enterprise Value is zł34.32 Mil.
Adiuvo Investments's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.50 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adiuvo Investments (WAR:ADV) has a EV-to-EBITDA of 68.37 as of Aug. 18, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Adiuvo Investments. According to the industry distribution chart, Adiuvo Investments ranks #475 out of 513 companies in the Medical Devices & Instruments industry, placing it in the top 92.6%.
Is Adiuvo Investments' EV-to-EBITDA too high?
Adiuvo Investments' current EV-to-EBITDA is 68.37. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.83. Adiuvo Investments' value of 68.37 is 361% above this industry median. Based on the distribution chart, Adiuvo Investments ranks #475 out of 513 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adiuvo Investments has a GF Score™ of 26/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Adiuvo Investments' EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Adiuvo Investments ranks #475 out of 513 companies for EV-to-EBITDA. This places Adiuvo Investments in the lower half of its industry. The industry median EV-to-EBITDA is 14.83. Adiuvo Investments' value of 68.37 is 361% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.83, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adiuvo Investments's current EV-to-EBITDA of 68.37 is 361% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Adiuvo Investments. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adiuvo Investments's current EV-to-EBITDA is 68.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adiuvo Investments stock overvalued right now?
Based on GuruFocus' analysis, Adiuvo Investments (WAR:ADV) is currently considered Modestly Overvalued. The stock's GF Value™ is zł0.47, compared to a current price of zł0.52 — trading 11.1% above its estimated fair value. The current EV-to-EBITDA is 68.37 and 361% above the Medical Devices & Instruments industry median of 14.83. Adiuvo Investments' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Adiuvo Investments (WAR:ADV), the current EV-to-EBITDA is 68.37 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adiuvo Investments (WAR:ADV) Overvalued in 2026?
Based on GuruFocus' analysis, Adiuvo Investments stock appears to be overvalued.
The current stock price of zł0.52 is trading 11.1% above its estimated GF Value™ of zł0.47.
GuruFocus considers Adiuvo Investments to be Modestly Overvalued.
Key valuation signals for WAR:ADV:
EV-to-EBITDA: 68.37
GF Value™: zł0.47 vs. price of zł0.52 (11.1% above fair value)
Industry Position: 361% above the Medical Devices & Instruments median (#475 of 513)
No single metric tells the full story. See the WAR:ADV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adiuvo Investments SA is engaged in the selection, development, financing and commercialization of projects in the international market. The new technologies developed by the company focus on disease management, monitoring healthy lifestyle and treatment with the help of mobile devices and supplementation and functional food, or food, which in addition to nutritional properties also has health properties.
26GF Score
Get the complete analysis for WAR:ADV
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ADV has been successfully added to your 
